A detailed history of Dfpg Investments, LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Dfpg Investments, LLC holds 4,347 shares of VRTX stock, worth $1.77 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
4,347
Holding current value
$1.77 Million
% of portfolio
0.14%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 09, 2024

BUY
$343.0 - $410.68 $1.49 Million - $1.79 Million
4,347 New
4,347 $1.77 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Dfpg Investments, LLC Portfolio

Follow Dfpg Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dfpg Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dfpg Investments, LLC with notifications on news.